Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines.

AIMS The present study was designed to decipher molecular mechanisms underlying nicotine's promoting atrial fibrillation (AF) by inducing atrial structural remodelling. METHODS AND RESULTS The canine model of AF was successfully established by nicotine administration and rapid pacing. The atrial fibroblasts isolated from healthy dogs were treated with nicotine. The role of microRNAs (miRNAs) on the expression and regulation of transforming growth factor-beta1 (TGF-beta1), TGF-beta receptor type II (TGF-betaRII), and collagen production was evaluated in vivo and in vitro. Administration of nicotine for 30 days increased AF vulnerability by approximately eight- to 15-fold in dogs. Nicotine stimulated remarkable collagen production and atrial fibrosis both in vitro in cultured canine atrial fibroblasts and in vivo in atrial tissues. Nicotine produced significant upregulation of expression of TGF-beta1 and TGF-betaRII at the protein level, and a 60-70% decrease in the levels of miRNAs miR-133 and miR-590. This downregulation of miR-133 and miR-590 partly accounts for the upregulation of TGF-beta1 and TGF-betaRII, because our data established TGF-beta1 and TGF-betaRII as targets for miR-133 and miR-590 repression. Transfection of miR-133 or miR-590 into cultured atrial fibroblasts decreased TGF-beta1 and TGF-betaRII levels and collagen content. These effects were abolished by the antisense oligonucleotides against miR-133 or miR-590. The effects of nicotine were prevented by an alpha7 nicotinic acetylcholine receptor antagonist. CONCLUSION We conclude that the profibrotic response to nicotine in canine atrium is critically dependent upon downregulation of miR-133 and miR-590.

[1]  S. Nattel,et al.  Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. , 2007, Cardiovascular research.

[2]  J. Armour,et al.  Role of peripheral autonomic neurones in maintaining adequate cardiac function. , 1995, Cardiovascular research.

[3]  J. Massagué,et al.  The TGF-β family and its composite receptors , 1994 .

[4]  M. Levin.  Rejected Landmarks: The Smoke Goes On-Reply , 1986 .

[5]  S Nattel,et al.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.

[6]  R. Cardinal,et al.  Spatially divergent cardiac responses to nicotinic stimulation of ganglionated plexus neurons in the canine heart , 2009, Autonomic Neuroscience.

[7]  M. Fishbein,et al.  Chronic nicotine in hearts with healed ventricular myocardial infarction promotes atrial flutter that resembles typical human atrial flutter. , 2005, American journal of physiology. Heart and circulatory physiology.

[8]  Baofeng Yang,et al.  Nicotine Is a Potent Blocker of the Cardiac A-Type K+ Channels: Effects on Cloned Kv4.3 Channels and Native Transient Outward Current , 2000, Circulation.

[9]  G. Jundt,et al.  In situ measurement of collagen synthesis by human bone cells with a Sirius Red-based colorimetric microassay: effects of transforming growth factor β2 and ascorbic acid 2-phosphate , 1999, Histochemistry and Cell Biology.

[10]  B. Strauss,et al.  The cardiac atria are chambers of active remodeling and dynamic collagen turnover during evolving heart failure. , 2004, Journal of the American College of Cardiology.

[11]  Robert B. Russell,et al.  Principles of MicroRNATarget Recognition , 2005 .

[12]  N. Benowitz,et al.  Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. , 1997, Journal of the American College of Cardiology.

[13]  A. Goette,et al.  Cigarette smoking induces atrial fibrosis in humans via nicotine , 2007, Heart.

[14]  D. Hopkins,et al.  Differential cardiac responses induced by nicotine sensitive canine atrial and ventricular neurones. , 1993, Cardiovascular research.

[15]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[16]  Sander Verheule,et al.  Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 , 2004, Circulation research.

[17]  Ruth Lehr,et al.  Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5). , 2002, Journal of medicinal chemistry.

[18]  Ursula Ravens,et al.  Remodeling of cardiomyocyte ion channels in human atrial fibrillation , 2003, Basic Research in Cardiology.

[19]  M. Sporn,et al.  Hyperthermia induces expression of transforming growth factor-beta s in rat cardiac cells in vitro and in vivo. , 1993, The Journal of clinical investigation.

[20]  S. T. Hanna,et al.  Effects of nicotine on K+ channel currents in vascular smooth muscle cells from rat tail arteries. , 1999, European journal of pharmacology.

[21]  Sam Griffiths-Jones,et al.  The microRNA Registry , 2004, Nucleic Acids Res..

[22]  T. Nilsen,et al.  Mechanisms of microRNA‐mediated gene regulation , 2007, Trends in genetics : TIG.

[23]  M. Marotta,et al.  Sensitive spectrophotometric method for the quantitative estimation of collagen. , 1985, Analytical biochemistry.

[24]  M. Longaker,et al.  In Vitro Analysis of Transforming Growth Factor-β1 Inhibition in Novel Transgenic SBE-Luciferase Mice , 2007, Annals of plastic surgery.

[25]  Hui-zhen Wang,et al.  Oxidative Preconditioning and Apoptosis in L-cells , 2001, The Journal of Biological Chemistry.

[26]  J. Armour.  Myocardial ischaemia and the cardiac nervous system. , 1999, Cardiovascular research.

[27]  N. Benowitz.  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. , 1988, The New England journal of medicine.

[28]  R. Russell,et al.  Principles of MicroRNA–Target Recognition , 2005, PLoS biology.

[29]  Jiening Xiao,et al.  Retracted: Transcriptional activation by stimulating protein 1 and post‐transcriptional repression by muscle‐specific microRNAs of IKs‐encoding genes and potential implications in regional heterogeneity of their expressions , 2007, Journal of cellular physiology.

[30]  Z. Wang,et al.  Nicotine depresses the functions of multiple cardiac potassium channels. , 1999, Life sciences.

[31]  Hui-zhen Wang,et al.  Progressive apoptotic cell death triggered by transient oxidative insult in H9c2 rat ventricular cells: a novel pattern of apoptosis and the mechanisms. , 2004, American journal of physiology. Heart and circulatory physiology.

[32]  M. Eghbali,et al.  Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor beta. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Abraham,et al.  Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. , 2008, Cytokine & growth factor reviews.

[34]  Nolwenn Le Meur,et al.  Contrasting Gene Expression Profiles in Two Canine Models of Atrial Fibrillation , 2007, Circulation research.

[35]  R. Brentani,et al.  Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections , 1979, The Histochemical Journal.

[36]  M. Eghbali,et al.  Cellular origin and distribution of transforming growth factor-β1 in the normal rat myocardium , 1989, Cell and Tissue Research.

[37]  M. Eghbali,et al.  Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. , 1991, Circulation research.

[38]  G. González,et al.  Histopathologic time course of myocardial infarct in rabbit hearts. , 2002, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[39]  S. Nattel,et al.  Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. , 2003, Cardiovascular research.

[40]  H. Karagueuzian,et al.  Age-related sensitivity to nicotine for inducible atrial tachycardia and atrial fibrillation. , 2003, American journal of physiology. Heart and circulatory physiology.

[41]  P. Stewart,et al.  Chronic nicotine ingestion and atrial fibrillation. , 1985, British heart journal.

[42]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[43]  S. Nattel,et al.  Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure , 2001, Circulation.

[44]  Y. Takeishi,et al.  Remodeling of the left atrium in pacing-induced atrial cardiomyopathy , 2002, Molecular and Cellular Biochemistry.

[45]  T. Regan,et al.  Influence of nicotine on myocardial stiffness and fibrosis during chronic ethanol use. , 1996, Alcoholism, clinical and experimental research.

[46]  V. Petrov,et al.  Induction of cardiac fibrosis by transforming growth factor-beta(1). , 2000, Molecular genetics and metabolism.

[47]  S. Nattel,et al.  Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. , 2004, Cardiovascular research.

[48]  R. Duisters,et al.  MIRNA-133 AND MIRNA-30 REGULATE CONNECTIVE TISSUE GROWTH FACTOR: IMPLICATIONS FOR A ROLE OF MIRNAS IN MYOCARDIAL MATRIX REMODELING , 2013 .

[49]  J. Armour,et al.  Modulation of in situ canine intrinsic cardiac neuronal activity by nicotinic, muscarinic, and beta-adrenergic agonists. , 1993, The American journal of physiology.

[50]  K. Eagle,et al.  Atrial fibrillation while chewing nicotine gum. , 1986, JAMA.

[51]  Richard J Jackson,et al.  How Do MicroRNAs Regulate Gene Expression? , 2007, Science's STKE.

[52]  S. Nattel.  New ideas about atrial fibrillation 50 years on , 2002, Nature.

[53]  W. Aronow,et al.  Nicotine gum-induced atrial fibrillation. , 2003, Heart disease.

[54]  Shokei Kim,et al.  Transforming growth factor β1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system , 1994 .

[55]  P. Anversa,et al.  Morphometric analysis of biologic processes. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[56]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[57]  Chaoqian Xu,et al.  The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 , 2011, Nature Medicine.